Fluidic systems and methods for analyses
Fluidic systems and methods for analysis are provided. In some embodiments, systems and methods for improved measurement of absorbance/transmission through fluidic systems are described. Specifically, in one set of embodiments, optical elements are fabricated on one side of a transparent fluidic device opposite a series of fluidic channels. The optical elements may guide incident light passing through the device such that most of the light is dispersed away from specific areas of the device, such as intervening portions between the fluidic channels. By decreasing the amount of light incident upon these intervening portions, the amount of noise in the detection signal can be decreased when using certain optical detection systems.
1. A multiplex assay system comprising:
an article supporting solid-phase assays, said article comprising a rigid planar substrate and comprising two or more different liquid containment regions, each liquid containment region comprising at least one analysis region that can be interrogated optically, each analysis region having one or more binding partners associated with a surface of the substrate, wherein said binding partners hind one or more analytes present in a sample in the liquid containment region, and wherein, for at least one liquid containment region, the one or more analytes is selected from the group consisting of prostate specific antigen (PSA), free PSA, complexed-PSA, pro-PSA, and human kallikrein protein (hk2); and
an optical device configured to supply collimated light to illuminate an analysis region of the two or more liquid containment regions and detect light from the illuminated analysis region.
2. The multiplex assay system of claim 1 , wherein the one or more binding partner is an antibody.
3. The multiplex assay system of claim 1 , wherein the sample is obtained from a whole blood, blood serum, or blood plasma sample.
4. The multiplex assay system of claim 1 , wherein each different liquid containment region is a chamber having a depth measured perpendicular to a surface of the rigid planar substrate and a cross-sectional dimension substantially parallel to the surface of the rigid planar substrate.
5. The multiplex assay system of claim 4 , wherein the chamber is integral to a surface of the rigid planar substrate.
6. The multiplex assay system of claim 4 , wherein the chamber comprises a separate structure connected to the rigid planar substrate.
7. The multiplex assay system of claim 6 , wherein the separate structure is connected to the rigid planar substrate through an adhesive and/or van der Waals forces.
8. The multiplex assay system of claim 7 , wherein the adhesive is an acrylic or silicone based adhesive.
9. The multiplex assay system of claim 4 , wherein the chamber is covered.
10. The multiplex assay system of claim 4 , wherein the chamber is uncovered.
11. The multiplex assay system of claim 1 , wherein each different liquid containment region is configured to contain less than 1 milliliter of liquid.
12. The multiplex assay system of claim 1 , wherein the optical device further comprises a camera or imaging system.
13. The multiplex assay system of claim 1 , wherein the optical device is configured to detect photoluminescence, fluorescence, chemiluminescence, bioluminescence, and/or electrochemiluminescence.
14. The multiplex assay system of claim 1 , wherein the rigid planar substrate is a polyethylene, polystyrene, polymethylmethacrylate, polycarbonate, poly(dimethylsiloxane), polytetrafluoroethylene, polyethylene terephthalate, or cyclo-olefin copolymer substrate.
15. The multiplex assay system of claim 14 , wherein the rigid planar substrate is a poly(dimethylsiloxane) substrate.
16. The multiplex assay system of claim 1 , wherein the rigid planar substrate is a glass, quartz, or silicon substrate.
17. The multiplex assay system of claim 1 , further comprising a second article comprising a rigid planar substrate comprising at least one analysis region in which one or more nucleic acid binding partners are associated with a surface of the substrate of the second article.
18. The multiplex assay system of claim 1 , wherein the optical device further comprises a focusing lens to focus the light that illuminates the analysis region.
19. The multiplex assay system of claim 1 , wherein the collimated light is supplied by directing light from a light source through a collimating lens.
20. A multiplex assay system comprising:
an article supporting solid-phase assays, said article comprising a rigid planar substrate and comprising two or more different liquid containment regions, each liquid containment region comprising at least one analysis region that can be interrogated optically, each analysis region having one or more binding partners associated with a surface of the substrate, wherein said binding partners bind one or more analytes present in a sample in the liquid containment region, and wherein, for at least one liquid containment region, the one or more analytes is selected from the group consisting of prostate specific antigen (PSA), free PSA, complexed-PSA, pro-PSA, and human kallikrein protein (hk2); and
an optical device configured to supply collimated light to illuminate an analysis region of the two or more liquid containment regions and detect light from the illuminated analysis region,
wherein the rigid planar substrate is composed of glass, quartz, or silicon; and
wherein the sample is obtained from a whole blood, blood serum, or blood plasma sample.
21. The multiplex assay system of claim 20 , wherein the optical device further comprises a focusing lens to focus the light that illuminates the analysis region.
22. The multiplex assay system of claim 20 , wherein the collimated light is supplied by directing light from a light source through a collimating lens.
23. The multiplex assay system of claim 1 , wherein the supplied collimated light and the detected light from the illuminated analysis region travel along a common path.
24. The multiplex assay system of claim 20 , wherein the supplied collimated light and the detected light from the illuminated analysis region travel along a common path.
25. The multiplex assay system of claim 1 , wherein the one or more binding partner is an antibody, wherein the sample is obtained from a whole blood, blood serum, or blood plasma sample, and wherein the supplied collimated light and the detected light from the illuminated analysis region travel along a common path.
26. The multiplex assay system of claim 20 , wherein the one or more binding partner is an antibody and wherein the supplied collimated light and the detected light from the illuminated analysis region travel along a common path.
27. The multiplex assay system of claim 1 , wherein each different liquid containment region is a chamber having a depth measured perpendicular to a surface of the rigid planar substrate and a cross-sectional dimension substantially parallel to the surface of the rigid planar substrate, wherein the chamber comprises a separate structure connected to the rigid planar substrate, and wherein the separate structure is connected to the rigid planar substrate through an adhesive and/or van der Waals forces.
28. The multiplex assay system of claim 20 , wherein each different liquid containment region is a chamber having a depth measured perpendicular to a surface of the rigid planar substrate and a cross-sectional dimension substantially parallel to the surface of the rigid planar substrate, wherein the chamber comprises a separate structure connected to the rigid planar substrate, and wherein the separate structure is connected to the rigid planar substrate through an adhesive and/or van der Waals forces.
29. The multiplex assay system of claim 1 , wherein each different liquid containment region is a chamber having a depth measured perpendicular to a surface of the rigid planar substrate and a cross-sectional dimension substantially parallel to the surface of the rigid planar substrate, wherein the chamber is uncovered, and wherein the optical device is configured to detect photoluminescence, fluorescence, chemiluminescence, bioluminescence, and/or electrochemiluminescence.
30. The multiplex assay system of claim 20 , wherein each different liquid containment region is a chamber having a depth measured perpendicular to a surface of the rigid planar substrate and a cross-sectional dimension substantially parallel to the surface of the rigid planar substrate, wherein the chamber is uncovered, and wherein the optical device is configured to detect photoluminescence, fluorescence, chemiluminescence, bioluminescence, and/or electrochemiluminescence.
31. The multiplex assay system of claim 1 , wherein the collimated light is supplied by directing light from a light source through a collimating lens and wherein the supplied collimated light and the detected light from the illuminated analysis region travel along a common path.
32. The multiplex assay system of claim 20 , wherein the collimated light is supplied by directing light from a light source through a collimating lens and wherein the supplied collimated light and the detected light from the illuminated analysis region travel along a common path.